158 related articles for article (PubMed ID: 31933179)
1. Risk of Extrapyramidal Syndromes Associated With Psychotropic Polypharmacy: A Study Based on Large-Scale Japanese Claims Data.
Hirano Y
Ther Innov Regul Sci; 2020 Mar; 54(2):259-268. PubMed ID: 31933179
[TBL] [Abstract][Full Text] [Related]
2. Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
Hirano Y; Ii Y
Clin Drug Investig; 2019 Nov; 39(11):1077-1092. PubMed ID: 31399894
[TBL] [Abstract][Full Text] [Related]
3. Prescribing Trends Psychotropic Drugs Against Children and Adolescents and Association with Polypharmacy Reduction Policy for Psychotropic Drugs: Based on Japanese National Database Survey.
Park J; Okui T; Nakashima N
Stud Health Technol Inform; 2022 Jun; 290():1132-1133. PubMed ID: 35673241
[TBL] [Abstract][Full Text] [Related]
4. Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis.
Okada Y; Akazawa M
Soc Psychiatry Psychiatr Epidemiol; 2022 Feb; 57(2):411-422. PubMed ID: 34333670
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of medical fee revisions for psychotropic polypharmacy in patients with mood disorders in Japan: An interrupted time-series analysis using a nationwide inpatient database.
Yamazaki R; Ohbe H; Matsuda Y; Kito S; Shigeta M; Morita K; Matsui H; Fushimi K; Yasunaga H
Asian J Psychiatr; 2023 Jun; 84():103581. PubMed ID: 37086613
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between Psychotropic Drug Use and Suicidal Behavior in Japan: Japanese Adverse Drug Event Report.
Takeuchi T; Takenoshita S; Taka F; Nakao M; Nomura K
Pharmacopsychiatry; 2017 Mar; 50(2):69-73. PubMed ID: 27595297
[No Abstract] [Full Text] [Related]
8. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
Inoue Y; Okumura Y; Fujita J
Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
[TBL] [Abstract][Full Text] [Related]
9. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Expression Profile of Extrapyramidal Symptoms Due to Antipsychotics by Data Mining of Japanese Adverse Drug Event Report (JADER) Database.
Kose E; Uno K; Hayashi H
Yakugaku Zasshi; 2017; 137(1):111-120. PubMed ID: 28049887
[TBL] [Abstract][Full Text] [Related]
11. A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy.
Brett J; Pearson SA; Daniels B; Wylie CE; Buckley NA
Br J Clin Pharmacol; 2021 Mar; 87(3):1369-1377. PubMed ID: 32881057
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics.
Yang SY; Chen LY; Najoan E; Kallivayalil RA; Viboonma K; Jamaluddin R; Javed A; Hoa DTQ; Iida H; Sim K; Swe T; He YL; Park Y; Ahmed HU; De Alwis A; Chiu HF; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK
Psychiatry Clin Neurosci; 2018 Aug; 72(8):572-579. PubMed ID: 29761577
[TBL] [Abstract][Full Text] [Related]
13. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
14. How psychotropic polypharmacy in schizophrenia begins: a longitudinal perspective.
Shinfuku M; Uchida H; Tsutsumi C; Suzuki T; Watanabe K; Kimura Y; Tsutsumi Y; Ishii K; Imasaka Y; Mimura M; Kapur S
Pharmacopsychiatry; 2012 Jun; 45(4):133-7. PubMed ID: 22174025
[TBL] [Abstract][Full Text] [Related]
15. Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study.
Kochi K; Sato I; Nishiyama C; Tanaka-Mizuno S; Doi Y; Arai M; Fujii Y; Matsunaga T; Ogawa Y; Furukawa TA; Kawakami K
Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):642-656. PubMed ID: 28266090
[TBL] [Abstract][Full Text] [Related]
16. Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: II. Psychotropics.
Seppala LJ; Wermelink AMAT; de Vries M; Ploegmakers KJ; van de Glind EMM; Daams JG; van der Velde N;
J Am Med Dir Assoc; 2018 Apr; 19(4):371.e11-371.e17. PubMed ID: 29402652
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
[TBL] [Abstract][Full Text] [Related]
18. Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia.
Stassen HH; Bachmann S; Bridler R; Cattapan K; Herzig D; Schneeberger A; Seifritz E
Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):603-619. PubMed ID: 34822007
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
20. Relationship between xerostomia and psychotropic drugs in patients with schizophrenia: evaluation using an oral moisture meter.
Okamoto A; Miyachi H; Tanaka K; Chikazu D; Miyaoka H
J Clin Pharm Ther; 2016 Dec; 41(6):684-688. PubMed ID: 27663579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
